NCT Number: NCT00392184
Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery
The purpose of this study is to determine whether accelerated partial breast irradiation (APBI) with multi-catheter brachytherapy is safe and effective.
Looking for future studies?
Notify MeKey information
Conditions
Age range
35 year–80 year
Sex eligibility
Female
Study type
Interventional
Phase
Phase 2
Primary location
Hospital Barmherzige Schwestern Linz, Linz, Austria
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- pT1/2 (≤ 3 cm)
- pN0 or pN1 mi
- M0 and no contralateral BC
- Clear margins (≥ 2 mm)
- Age ≥ 35 years
- ER and/or PR positive
Exclusion criteria
- Multifocality or Multicentricity
- EIC
- Lymphovascular invasion
- Poorly differentiated tumors
- Diffuse microcalcifications
Treatment and study plan
Sponsors and collaborators
Lead sponsor
University of Erlangen-Nürnberg Medical School
Other
Registry information
Important dates
- Study start
- 2000
- Primary completion
- 2009
- Study completion
- 2010
- First posted
- Oct 25, 2006
- Registry last updated
- Jun 1, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Tumor-Derived FGF19
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsAfrican Cancer Genome: GMD
NCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial Details24GUT540 : Meeting of Breast Cancer Patients and Pathologists
NCT07040514
Breast Cancer, Breast Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNeoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer
NCT06604858
Breast Cancer, Breast Diseases
A Coruña, Spain
View Trial Details